A triple negative breast cancer: what it is not!
Suresh B KatakkarRegional Medical Oncology Hematology Leader, Centre for the North, BC Cancer Agency, Prince George, British Columbia, CanadaAbstract: The triple negative cancer is an unusual, and at the same time, a unique entity where the discordance rate is almost 18%. That means 18% of Her2 nega...
Enregistré dans:
Auteur principal: | Katakkar SB |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2012
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/34d96f55e3a545ba965c23956564a1ec |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Triple negative breast cancer: an Indian perspective
par: Akhtar M, et autres
Publié: (2015) -
Molecular heterogeneity in adjacent cells in triple-negative breast cancer
par: Huebschman ML, et autres
Publié: (2015) -
Protein truncating variants in FANCM and risk for ER-negative/triple negative breast cancer
par: Paolo Peterlongo, et autres
Publié: (2021) -
Androgen receptor as a mediator and biomarker of radioresistance in triple-negative breast cancer
par: Corey Speers, et autres
Publié: (2017) -
A DNA methylation-based liquid biopsy for triple-negative breast cancer
par: Katrina Cristall, et autres
Publié: (2021)